Adma Biologics (ADMA) Current Deferred Revenue (2016 - 2025)
Adma Biologics (ADMA) recorded Current Deferred Revenue of $143,000 in Q2 2025, down 87.3% from $1.13 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) Current Deferred Revenue (2016 - 2025) Analysis & Trends
Starting with Q4 2016, Adma Biologics' Current Deferred Revenue history includes 24 quarters.
- Annual Current Deferred Revenue has a five-year compound annual growth rate of 0.0% (FY2019 to FY2024).
- Across earlier years, Current Deferred Revenue came in at $182,000 in FY2023 (+27.3%), $143,000 in FY2022 (+0.1%), $142,834 in FY2021 (unchanged) and $142,834 in FY2020 (unchanged).
- Quarterly Current Deferred Revenue has ranged from $142,834 in Q3 2020 to $1.13 million in Q2 2024 over the past five years.
- On a year-over-year basis, Current Deferred Revenue has declined for three consecutive quarters, with growth averaging 150.7% over the last eight quarters.
- Peak year-over-year performance for Current Deferred Revenue in the last five years was growth of 691.1% in Q2 2024, against a decline of 87.3% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $143,000 (Q1 2025), $143,000 (Q4 2024) and $143,000 (Q3 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Adma Biologics | 2.87 Bn | 2.39 Bn | 99.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 143,000.00 |
| Mar 31, 2025 | 143,000.00 |
| Dec 31, 2024 | 143,000.00 |
| Sep 30, 2024 | 143,000.00 |
| Jun 30, 2024 | 1.13 Mn |
| Mar 31, 2024 | 1.12 Mn |
| Dec 31, 2023 | 182,000.00 |
| Sep 30, 2023 | 142,834.00 |
| Jun 30, 2023 | 142,834.00 |
| Mar 31, 2023 | 142,834.00 |
| Dec 31, 2022 | 143,000.00 |
| Sep 30, 2022 | 142,834.00 |
| Jun 30, 2022 | 142,834.00 |
| Mar 31, 2022 | 142,834.00 |
| Dec 31, 2021 | 142,834.00 |
| Sep 30, 2021 | 142,834.00 |
| Jun 30, 2021 | 142,834.00 |
| Mar 31, 2021 | 142,834.00 |
| Dec 31, 2020 | 142,834.00 |
| Sep 30, 2020 | 142,834.00 |
API Access
Adma Biologics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();